The national drug watchdog has revoked Anhui Huayuan Worldbest
Biology Pharmacy Corporation's production license for injections
and dismissed the company's top management.
The manufacture of "Xinfu" drugs, which allegedly caused six
deaths in the country in July, is banned, spokesman Zhang Jixiang
with the State Food and Drug Administration said on Monday.
He said that the "Xinfu" antibiotic injection was of inferior
quality. The company's Good Manufacturing Practice Certificate and
its production license for "Xinfu" drugs have been revoked.
The Anhui Provincial Food and Drug Bureau will supervise the
destruction of all the recalled drugs.
The bureau will seize illegal company funds and impose a fine in
line with China's Drug Management Law, Zhang said.
Five management staff including general manager Qiu Zuyi,
executive deputy general manager Zhou Cang, deputy general manager
Pan Wei, Plant II director Yuan Haiyuan and quality supervisor Cui
Tongxin were dismissed for their responsibility in respect to the
suspect killer antibiotic.
Another five people including legal representative Sun Ying,
production director Liu Jiansong, Plant II vice directors Jia Yibo
and Wang Dianlin and technician Chen Ping each were given a
"serious demerit", Zhang said.
Director Zhang Guodong and vice director Shang Wenxue of the
Food and Drug Bureau of Fuyang City received administrative
sanctions.
Zhang said that the "Xinfu" incident had unveiled "glaring
problems" among China's drug manufacturers and "deficient
supervision" by drug authorities.
(Xinhua News Agency October 16, 2006)